SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 580 filers reported holding SEAGEN INC in Q1 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,865,000 | +0.3% | 60,639 | -9.0% | 0.06% | +9.6% |
Q2 2023 | $12,831,000 | -10.5% | 66,667 | -5.9% | 0.05% | -13.3% |
Q1 2023 | $14,342,000 | +48.7% | 70,833 | -5.6% | 0.06% | +42.9% |
Q4 2022 | $9,647,000 | -10.3% | 75,071 | -4.5% | 0.04% | -14.3% |
Q3 2022 | $10,754,000 | -10.6% | 78,596 | +15.7% | 0.05% | -3.9% |
Q2 2022 | $12,024,000 | +18.7% | 67,956 | -3.4% | 0.05% | +41.7% |
Q1 2022 | $10,129,000 | -8.6% | 70,317 | -2.0% | 0.04% | -2.7% |
Q4 2021 | $11,088,000 | -12.3% | 71,721 | -3.7% | 0.04% | -17.8% |
Q3 2021 | $12,650,000 | +5.2% | 74,498 | -2.2% | 0.04% | +7.1% |
Q2 2021 | $12,026,000 | +28.6% | 76,174 | +13.1% | 0.04% | +13.5% |
Q1 2021 | $9,351,000 | -15.3% | 67,341 | +6.8% | 0.04% | -26.0% |
Q4 2020 | $11,040,000 | +15.1% | 63,036 | +28.6% | 0.05% | -3.8% |
Q3 2020 | $9,593,000 | – | 49,021 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |